OBJECTIVES: Mesenteric ischaemia (MesI) remains a rare but lethal complication following cardiac surgery. Previously identified risk factors for MesI mortality (age, poor left ventricular (LV) function, cardiopulmonary bypass time and blood loss) are non-specific and cannot necessarily be modified. This study aims to identify potentially modifiable risk factors for MesI mortality through analysis of periand intraoperative perfusion data.
INTRODUCTION
Mesenteric ischaemia (MesI) is a rare complication following cardiac surgery, with an estimated incidence of 0.49-2% [1, 2] . Although it is rare, it carries a high risk of mortality (60-100%), prolonged postoperative recovery and impaired long-term survival [3] [4] [5] . Diagnosis of MesI following cardiac surgery is difficult. The initial symptoms and signs of abdominal pain, distension and guarding are not apparent in sedated, ventilated patients. Even in the awake patient, the signs may be masked following cardiac surgery due to confounding pain from the sternotomy incision or drain sites. Other clinical signs may be equally explained by ileus, postoperative nausea and vomiting or opiate analgesia, all of which are common after cardiac surgery. If MesI is present, patient survival relies on prompt identification of the condition and laparotomy. Attention has therefore been focused on predicting which patients are particularly vulnerable to MesI. Thus, it is important to understand the causative process with a view to identifying modifiable risk factors.
It has been speculated that occlusive mesenteric arterial or venous thromboembolism cause MesI. However, more recent evidence suggests a mechanism of low mesenteric blood flow following a low cardiac output state as an important factor in the development of MesI following cardiac surgery [6] [7] [8] . In a previous study from our own institution, we found that, in patients with MesI following cardiac surgery, the incidence of a non occlusive cause was as high as 96% [2] .
In keeping with a hypothesis of low-flow aetiology, previous researchers have independently identified that the following parameters significantly increase the risk of MesI mortality following cardiac surgery: age >65 years, poor left ventricular function, recent myocardial infarction (MI, within 90 days of surgery), peripheral vascular disease (PVD), prolonged bypass time, haemodynamic instability, excessive blood loss and postoperative atrial fibrillation [5, [8] [9] [10] . One group has even proposed a risk prediction tool for MesI based on these parameters [11] . Unfortunately, most risk factors identified thus far are not modifiable. This study focuses on identifying any modifiable risk factors in patients who are known to be at high risk of MesI mortality.
METHODS

Patient selection, data collection and definition of parameters
Our institutional database was interrogated retrospectively to identify patients who underwent cardiac surgery between 2006 and 2011. One patient undergoing thoraco abdominal aneurysm repair was excluded, because this operation adds further technical causes of MesI. Patients undergoing off-pump procedures were also excluded from our analysis, partly because only a small proportion of patients undergo off-pump surgery, but also because we specifically aimed to study parameters related to extracorporeal perfusion during the operation. The remaining patients were stratified according to clinical outcomes in the following manner: (i) Group A patients died following cardiac surgery with MesI stated as the primary cause of death on the death certificate; (ii) Group B patients died following cardiac surgery, but from another cause (as declared on the death certificate); (iii) Group C patients had cardiac surgery and survived to discharge despite any complications.
This study was facilitated by the fact that 70% of our in-hospital deaths undergo a post-mortem examination. However, a postmortem is not mandatory if the cause of death can be confidently declared by the treating physicians. Therefore, causes of death were taken from the death certificates.
After dividing the surgical population into the 3 groups, the MesI risk prediction tool published by Chauduri et al. [11] was used to estimate risk of MesI for each patient and then create 3 cohorts of patients from Groups A, B and C matched for risk of MesI, rounded to whole integers ( Table 1 ). The tool matches for age, postoperative inotrope, postoperative renal replacement therapy, postoperative ventilation >48 h and postoperative atrial fibrillation.
Post-mortem reports for patients in Groups A and B (if available) were collected and reviewed to identify evidence of perioperative MI, left ventricular hypertrophy, mesenteric arteriopathy and the pattern of bowel ischaemia (localized, likely to be large vessel aetiology versus generalized, and likely to be microvascular malperfusion). For all patients in Groups A, B and C, preoperative, intraoperative and postoperative data were reviewed. The full list of parameters collected is in Table 2 .
Intraoperative management
At our institution, cardiopulmonary bypass is run in accordance with Cambridge Perfusion Services perfusion protocol. The targets are average activated clotting time over 400 s and cardiac index above 2.4 throughout the case. During the operation, perfusion parameters are recorded every 15 min and the charts are stored on site. Flows, pressures and vasopressor usage during cardiopulmonary bypass are adjusted at the discretion of the surgeon, anaesthetist and perfusionist.
Postoperative management
After the operation, patients are transferred to intensive care with invasive arterial and central venous pressure monitoring. In cases where a low cardiac output state is suspected, invasive cardiac monitoring is achieved with a Swann-Ganz pulmonary artery catheter. First-line inotropic agents in our hospital are dopamine, adrenaline, noradrenaline and enoximone. Mechanical support (i.e. venoarterial extracorporeal membrane oxygenation or ventricular assist devices) is available for patients in unremitting low cardiac output state, but was not indicated in any of the patients in the study populations. Intra-aortic balloon pumps are also available and their pre-and postoperative usage were also collected. Patients who die of any cause within 30 days of cardiac surgery are referred to HM Coroner's Officers and most proceed to postmortem examination. Cause of death (stratified into parts 1a, 1b, 1c and 2) is recorded within our institutional database. 
Statistical analysis
Descriptive summary statistics relating to preoperative, interoperative and postoperative characteristics were calculated within each patient group. Statistically significant between-group differences were identified using Cochan's Q test for categorical variables and Friedman's test for the ordinal or continuous variables. Conditional logistic regression was used to investigate predictors of death from MesI, based on 1:2 matching comparing Group A with Groups B and C together. We used conditional logistic regression rather than ordinary logistic regression because patients were matched by MesI risk score. Separate univariate conditional logistic regression models were fitted to the outcome variable (MesI mortality) for each explanatory variable of interest, such that only one explanatory variable was included in the regression models at any one time. It was not possible to perform multiple regression analysis or investigate interaction effects due to the small sample size.
A 5% significance level was used throughout. R version 2. 
RESULTS
During our study period, 10 409 patients underwent cardiac surgery. Thirty patients were confirmed to have died of MesI. Two hundred and sixty-one patients died of other causes. Ten thousand one hundred and eighteen patients had cardiac surgery and survived to discharge (Fig. 1) . The mean logistic EuroSCORE for the overall population was 20.2 (SD 19.9), mean age was 75.5 years (SD 7.12) and overall in-hospital mortality was 2.9%. Five cases of MesI deaths had to be discarded because case notes were unavailable or electronic records were incomplete, leaving 25 cases to be riskmatched. Thus, 3 matched cohorts were created from Groups A, B and C, as described above and each containing 25 patients.
Fourteen of the 25 patients (64%) in Group A and 21 (84%) of the 25 patients in Group B had post-mortems. After review, it was found that 1 patient in Group A and none in Group B had mesenteric arteriopathy. In that 1 patient, the superior mesenteric artery was narrowed, but the pattern of bowel ischaemia was generalized and not restricted to superior mesenteric artery territory. Twenty-one percent of Group A patients and 33% of Group B patients had post-mortem evidence of perioperative myocardial infarct that may have contributed to a low cardiac output state. Ninety-two percent of patients in Group A and 76% of patients in Group B had evidence of left ventricular hypertrophy (defined as heart weight >500 g). Table 3 demonstrates the preoperative, intraoperative and postoperative characteristics of the 3 groups. Significant differences between groups were found for the following variables: redo rate, recent MI, standard EuroSCORE, metaraminol dose, percentage filtered while on bypass, percentage intra-aortic balloon pump (IABP), lowest documented mean arterial pressure, total volume of blood products transfused in hospital, volume of fresh-frozen plasma transfused, volume of platelets transfused and volume of red blood cells transfused. Most variables showed a similar pattern of results whereby the largest differences were seen between Groups A and C (MesI deaths vs survivors), with a few exceptions: 48% of patients had a recent MI in the MesI deaths group compared with only 8 and 20% in the non-MesI death and survivor Univariate conditional regression analysis was performed to analyse which factors were predictive of MesI deaths. Recent MI (OR 4.98, 95% CI 1.58-15.71), standard EuroSCORE (OR 1.12, 95% CI 1.03-1.21), metaraminol dose (OR 1.52, 95% CI 1.12-2.06) and total vasopressor use (OR 1.28, 95% CI 1.04-1.57) were significant predictors of death from MesI at the 5% level. Patients with lower minimum values of mean arterial pressure were also significantly more likely to die from Mesl (OR 0.90, 95% CI 0.83-0.97). PVD, red blood cell transfusion and cryoprecipitate transfusion were also significant predictors at the 10% level ( Table 4 ). The variable 'Redo' had sparse data and, therefore, the conditional logistic regression model did not fit when this variable was included as an explanatory variable in the model. An McNemar's test was performed instead (comparing Group A with the other two groups), which gave a P-value of 0.0005. The regression results corresponding to 'age' and 'blood loss' were not presented because they were used as matching variables in the study design.
DISCUSSION
Our study design has yielded new information about risk factors for MesI mortality and the role of intraoperative factors. Our data demonstrate that redo surgery, recent MI, standard EuroSCORE, metaraminol dose, total vasopressor dose and lowest documented blood pressure (BP) are associated with death from MesI following cardiac surgery.
Patients undergoing cardiac surgery inherently have risk factors and associations with PVD. The risk of embolic phenomena following cardiopulmonary bypass is also well documented. It has been speculated that occlusive arterial or venous thromboembolism may be responsible for MesI following cardiac surgery. Recent evidence, however, disputes this, with only 4% of MesI after cardiac surgery being related to thromboembolism [2] . Current opinion favours the mechanism of low mesenteric blood flow following a low cardiac output state as the most important association with the development of MesI following cardiac surgery [6] [7] [8] . The hypothesis is that inadequate perfusion leads to intestinal intramucosal acidosis, which leads to a 'vicious cycle' of increased microvascular permeability and cytokine production that worsens sub-mucosal oxygen delivery and creates the substrate for MesI. It is possible that MesI after cardiac surgery follows after a multihit phenomenon where there are sequential low-flow insults to the periphery of the intestinal villi. Our data support this hypothesis by demonstrating that recent MI and intraoperative vasopressor dose are specifically predictive of MesI. The first 'hit' to intestinal perfusion may occur during the preoperative MI. The secondary hit(s) may occur intraoperatively, either due to the low pressure state requiring administration of vasopressor or due to the effects of vasopressor itself. Subsequent hits may occur due to microemboli while coming off bypass, low cardiac output or atrial fibrillation postoperatively.
The preoperative risk factors cannot be modified. Postoperatively, the low cardiac output state is already recognized as a forerunner to high morbidity and mortality. It is therefore already treated aggressively with invasive cardiac output monitoring and inotropic support. However, there may be scope for modification of intraoperative variables, specifically as regards the management of extracorporeal perfusion. In an emergency case, there may be no alternative to high vasopressor dose if the patient is profoundly vasodilatated for any reason. However, in an elective scenario, measures such as mandatory cessation of vasodilatory drugs may be helpful for patients who are anticipated to be at high risk of MesI. Intraoperatively, it may be possible for the perfusionist to 'overflow' on cardiopulmonary bypass rather than use vasopressors to generate systemic pressure. Equally, it may even be appropriate to accept lower pressure as long as adequate flow (as evaluated by cardiac index) is maintained. It is also possible that normothermia with warm blood cardioplegia could be protective against MesI by reducing the severity of perioperative MI and/or low cardiac output state. Our study has shown that low postoperative blood pressure was associated with MesI, but we cannot determine from our recorded data whether the hypotension was due to low cardiac output, sepsis or vasoplegia. On the other hand, intra-aortic balloon pumps, which are used often and early in our institution for patients with low cardiac output syndrome were not associated with MesI. Therefore, we suspect that normothermia and warm blood plegia may help prevent MesI in high-risk patients, but there is inadequate information from this study to support this proposal.
Indeed, the benefit of any preventative strategies for MesI is difficult to evaluate scientifically because the incidence of MesI after cardiac surgery is so low. A prospective randomized study would require several thousand patients to be adequately powered. Therefore, we believe that, despite the limitations of a retrospective analysis, matched cohort studies may be the best approach to studying clinical methods of preventing MesI. Preventing MesI is a particularly worthwhile goal because diagnosing and treating MesI in patients after cardiac surgery is so difficult. The most useful diagnostic test available for a sedated patient with abdominal signs is CT with contrast medium. However, this has poor sensitivity and specificity for MesI. Furthermore, it is relatively contraindicated in our patient group, who are likely to be unstable by the very nature of the problem and at heightened risk of contrast-induced nephropathy. CT mesenteric angiography is the most sensitive and specific test for acute MesI and has the additional benefit of enabling interventions, such as injections of papaverine to cause local vasodilatation and embolization of thrombus. However, this is a sophisticated investigation that can be performed only in specialist centres. With regard to treatment options, laparotomy and bowel resection is the most common treatment for MesI, but only if a limited length of bowel is affected. The morbidity and mortality of such an operation is high. 
LIMITATIONS
There are several difficulties inherent in studying MesI after cardiac surgery. The first is that the incidence of the complication is very low. Consequently, in this study, only 25 MesI patients could be identified who could be matched. Despite the small sample sizes, we were able to identify statistically significant differences in the perfusion parameters. However, the sample size was not high enough to attempt multivariate analysis, and it is possible that some of the relations observed may be due to the presence of confounding variables. Another major limitation in studying the topic is that there is no practical method for analysing mesenteric perfusion. This causes a problem both for diagnosing MesI and for evaluating the relative effects of drugs, perfusion methods or treatments on mesenteric perfusion. Mesenteric flow probes might alleviate this problem but are impractical to use in postoperative patients. Therefore, their use is likely to remain experimental. 
